Clinical Trials · NCT00131144
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novartis
- Enrollment
- 583
- Start date
- Nov 1999
- Locations
- 1 site, United States
- Primary endpoint
- time to progression of diabetic retinopathy